Health front page macrophage2

The

Nano-Safety Research Group

Specialists in the assessment of nanomaterial toxicity to human health and the environment

BIORIMA

BIORIMA - BIOmaterial RIsk MAnagement

Funding: EU H2020 Nov 2017- Oct 2021  - Euro's  million total (250k to HWU)

Background: Currently nano-biomaterials are used in a wide range of advanced medicines and medical devices.  The current regulatory frameworks require risk assessment for approval.  While a range of regulations exist that are applicable to

Goal: To develop an Integrated Risk Management Framework for Nano-Biomaterials used in Advanced Medicine and Medical Devices

BIORIMA will develop an Integrated Risk Management Tool.  HWU will contribute to the development of this tool by building an Integrated Approach to Testing and Assessment (IATA) in order to guide and streamline the hazard testing, in order to improve effeciency and reduce animal usage.